Northern Institute for Cancer Research

Staff Profile

Dr Lynsey McKenzie

Research Associate

Background

Post-doctoral Research Associate

Publications

  • Martinez-Soria N, McKenzie L, Draper J, Ptasinska A, Issa H, Potluri S, Blair HJ, Pickin A, Isa A, Chin PS, Tirtakusuma R, Coleman D, Nakjang S, Assi S, Forster V, Reza M, Law E, Berry P, Mueller D, Elder A, Bomken SN, Pal D, Allan JM, Veal GJ, Cockerill PN, Wichmann C, Vormoor J, Lacaud G, Bonifer C, Heidenreich O. The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation. Cancer Cell 2018, 34(4), 626-642.e8.
  • McKenzie L, Martinez-Soria N, Draper J, Nakjang S, Blair HJ, Wichmann C, Vormoor J, Bonifer C, Lacaud G, Heidenreich O. Identification of CCND2 As a RUNX1/ETO Target Required for Leukaemic Propagation. Blood 2016, 128(22), 835.
  • Martinez N, McKenzie LM, Nakang S, Ptasinska A, Assi SA, Bonifer C, Heidenreich O. Identification of RUNX1/ETO Targets Required for Leukaemic Propagation. In: HAEMATOLOGICA. 2015, Vienna, Austria: Fondazione Ferrata Storti.
  • McKenzie L, King S, Dias S, Marcar L, Nicol S, Schumm K, Robertson P, Bourdon JC, Perkins N, Fuller-Pace F, Meek DW. p53-dependent repression of Polo-like Kinase-1, PLK1. Cell Cycle 2010, 9:20, 4200-4212.
  • Allende-Vega N, McKenzie L, Meek D. Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2. Molecular and Cellular Biochemistry 2008, 316(1-2), 99-106.